A drug best known for sparking romance may soon find a new role on the battlefield against cancer. Sildenafil, the active ingredient in Viagra, famous for treating erectile dysfunction, has emerged from the shadows of its primary use to reveal a surprising potential: slowing the spread of cancer. Recent research from leading scientists at the Weizmann Institute of Science and collaborators has uncovered how this little blue pill might interfere with a cancer cell’s ability...
BREAKING NEWS







